According to new research from the University of Kansas Medical Center, high-dose intravenous vitamin C, coupled with conventional cancer therapy, showed a noticeable improvement against the ill effects of chemotherapy drugs. The study, which consisted of 27 newly diagnosed patients with stage 3 and 4 ovarian cancer and was published in the Feb 5. Issue of Science Translational Medicine, showed that vitamin C works at the cellular level. And in mice, the study showed that intravenous vitamin C actually kills cancer cells with little or no damage to various organs.
Intravenous vitamins have the unique ability to bypass the liver. This fundamental difference is what makes intravenous vitamin C so powerful. Unlike oral vitamins, intravenous vitamin C can avoid the gut and boost plasma levels. As the intravenous vitamin C overtakes the cancer cells, it leaves the non-infected cells intact. “It seemed to be protecting the healthy cells while killing the cancer cells,” said Jeanne Drisko, director of integrative medicine at the University of Kansas Medical Center.
In addition to the die-off effect, researchers saw a nearly 9 month increase in time before the disease began to progress, as opposed to the chemo only test group. When administered, the intravenous vitamin C turns intro hydrogen peroxide – which at high enough levels – inhibits tumor growth.
As researchers continue to debate the anti-cancer effects of intravenous vitamin C, the end result of the study is undeniably positive. At The Salerno Center for Complementary Medicine, we faithfully use intravenous vitamin C therapy on patients to help prevent and combat disease, and have witnessed amazing firsthand results. Not only does intravenous vitamin C therapy treat symptoms, but more importantly, it treats the underlying root causes of disease.
